Salix Pharmaceuticals Reports 1Q2012 Results - Yahoo Finance

Cash and cash equivalents were $665.9 million as of March 31, 2012 Adam Derbyshire, Executive Vice President and Chief Financial Officer, stated, “XIFAXAN 550 mg continued to perform well during the first quarter of 2012. During the quarter ...

Salix Pharmaceuticals, Ltd. : Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2012 - 4-traders (press release)

"Effect of Methylnaltrexone on Esophageal Function in Man" About XIFAXAN ® (rifaximin) 550 mg tablets Important Safety Information XIFAXAN 550 mg is indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients ? 18 years of age.

Salix first quarter total product revenue increases 62% to $171.1M - News-Medical.Net

Cash and cash equivalents were $665.9 million as of March 31, 2012 Adam Derbyshire, Executive Vice President and Chief Financial Officer, stated, "XIFAXAN 550 mg continued to perform well during the first quarter of 2012. During the quarter our ...

The hepatic encephalopathy market is forecast to show growth until 2019 - Transworld News

Antibiotics are used as second-line agents and include drugs such as Xifaxan 550mg, neomycin and metronidazole. Xifaxan 550mg is an antibiotic from Salix Pharmaceuticals, which is the only approved drug for the long term treatment of recurrent overt ...

They May Look Alike, But Treat Parasites Differently: Doctor - Voice of America

Traveler's diarrhea can be treated with ciprofloxacin, 500 mg twice daily for three days, or xifaxan (rifaximin), 200 mg three times daily for three days.

Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2012 - Yahoo Finance

“Effect of Methylnaltrexone on Esophageal Function in Man” XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN. Hypersensitivity ...

Salix Pharmaceuticals, Inc. (SLXP) - Financial and Strategic SWOT Analysis Review - new company profile report - Transworld News

The company's product Xifaxan is a gastrointestinal-specific oral antibiotic that the Food and Drug Administration (FDA) approved for the treatment of patients 12 years of age and older with travelers' diarrhea caused by noninvasive strains of E coli.

5 Steps to Kill Hidden Bugs in Your Gut That Make You Sick - Huffington Post

A recent study in the New England Journal of Medicine found that you could cure or prevent delirium and brain fog in patients with liver failure by giving them an antibiotic called Xifaxan to clear out bugs that produce toxins their poor livers couldn't detoxify.(

Antibiotics/Probiotics Helpful in Irritable Bowel Syndrome - familypracticenews.com

He noted that a recent meta-analysis concluded that oral rifaximin (Xifaxan) provides significant short-term relief of bloating as well as improved global quality of life scores in patients with IBS. The meta-analysis included five randomized, placebo ...